Response to correspondence by Dr Aamar on ‘EULAR recommendations for the management of rheumatoid arthritis with synthetic and biologic disease-modifying antirheumatic drugs: 2025 update’
Annals of the Rheumatic Diseases · 2026-09 · 85 (9) · e100-e101
DOI: 10.1016/j.ard.2026.06.026 ↗Kurz gefasst
Leserbrief in der Zeitschrift Annals of the Rheumatic Diseases, 2026-09. Verfasst von Josef S Smolen und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Rheumatology, Department of Medicine 3,Medical University of Vienna, Austria. Electronic address: josef.smolen@meduniwien.ac.at. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 8 Literaturangaben. Gefördert von: European League Against Rheumatism.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Division of Rheumatology, Department of Medicine 3,Medical University of Vienna, Austria. Electronic address: josef.smolen@meduniwien.ac.at.
- NIHR Southampton Clinical Research Facility,University Hospital Southampton NHS Foundation Trust, Southampton, UK.
- Division of Rheumatology, Department of Medicine 3,Medical University of Vienna, Austria.
- MRC Lifecourse Epidemiology Centre, Southampton, UK.
- Amsterdam University Medical Center, Amsterdam and Zuyderland MC, Heerlen, the Netherlands.
Förderung
- European League Against Rheumatism
Zitieren
APA
Smolen, J. S., Edwards, C. J., Konzett, V., Laskou, F., Landewe, R., & Kerschbaumer, A. (2026). Response to correspondence by Dr Aamar on ‘EULAR recommendations for the management of rheumatoid arthritis with synthetic and biologic disease-modifying antirheumatic drugs: 2025 update’. Annals of the Rheumatic Diseases, 85(9), e100-e101. https://doi.org/10.1016/j.ard.2026.06.026
Vancouver
Smolen JS, Edwards CJ, Konzett V, Laskou F, Landewe R, Kerschbaumer A. Response to correspondence by Dr Aamar on ‘EULAR recommendations for the management of rheumatoid arthritis with synthetic and biologic disease-modifying antirheumatic drugs: 2025 update’. Annals of the Rheumatic Diseases. 2026;85(9):e100-e101. doi:10.1016/j.ard.2026.06.026
BibTeX
@article{Smolen2026,
author = {Smolen, Josef S and Edwards, Christopher J and Konzett, Victoria and Laskou, Faidra and Landewe, Robert and Kerschbaumer, Andreas},
title = {Response to correspondence by Dr Aamar on ‘EULAR recommendations for the management of rheumatoid arthritis with synthetic and biologic disease-modifying antirheumatic drugs: 2025 update’},
journal = {Annals of the Rheumatic Diseases},
year = {2026},
volume = {85},
number = {9},
pages = {e100--e101},
doi = {10.1016/j.ard.2026.06.026}
}
EUVIMED